Bio-Techne (TECH) Gross Profit (2009 - 2026)

Bio-Techne (TECH) posted quarterly Gross Profit of $208.3 million for Q1 2026, down 2.92% year-over-year from $214.6 million in Q1 2025, and up 8.89% quarter-over-quarter from $191.3 million in Q4 2025.

Bio-Techne (TECH) Gross Profit (2009 - 2026) Analysis & Trends

Bio-Techne's Gross Profit history runs 18 years deep, the most recent figure standing at $208.3 million for Q1 2026.

  • In Q1 2026, Gross Profit fell 2.92% year-over-year to $208.3 million; the TTM figure through Mar 2026 stood at $786.5 million (down 1.05% YoY), while the FY2025 annual figure was $790.3 million, up 2.67% from the prior year.
  • Gross Profit for Q1 2026 stood at $208.3 million, up from $191.3 million in the prior quarter.
  • The five-year high for Gross Profit was $214.6 million in Q1 2025, with the low at $176.6 million in Q4 2023.
  • The 5-year median for Gross Profit is $198.8 million (2025), against an average of $195.3 million.
  • The sharpest annual moves came in 2022 and 2023: Gross Profit advanced 19.72% in 2022, then slipped 3.69% in 2023.
  • Bio-Techne's Gross Profit stood at $183.4 million in 2022, then declined by 3.69% to $176.6 million in 2023, then grew by 9.8% to $193.9 million in 2024, then dropped by 1.35% to $191.3 million in 2025, then advanced by 8.89% to $208.3 million in 2026.
  • Business Quant data shows TECH's Gross Profit at $208.3 million in Q1 2026, $191.3 million in Q4 2025, and $188.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Bio-Techne 11.33 Bn 11.12 Bn 208.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 208.29 Mn
Mar 31, 2026 208.29 Mn
Dec 31, 2025 191.28 Mn
Dec 31, 2025 191.28 Mn
Sep 30, 2025 188.11 Mn
Sep 30, 2025 188.11 Mn
Jun 30, 2025 198.81 Mn
Jun 30, 2025 198.81 Mn
Mar 31, 2025 214.56 Mn
Mar 31, 2025 214.56 Mn
Dec 31, 2024 193.89 Mn
Dec 31, 2024 193.89 Mn
Sep 30, 2024 183.02 Mn
Sep 30, 2024 183.02 Mn
Jun 30, 2024 203.35 Mn
Jun 30, 2024 203.35 Mn
Mar 31, 2024 204.60 Mn
Mar 31, 2024 204.60 Mn
Dec 31, 2023 176.59 Mn
Dec 31, 2023 176.59 Mn